Dysregulation of this pathway is common in various cancers, with activated PI3K/AKT signaling associated with multiple processes, including the induction of tumor cell proliferation, inhibition of apoptosis, and promotion of invasion and metastasis (Yang et al. 2019). The gene discussed is AKT1; the disease is cancer.